SY

Smitha Yalamanchili

Active Director Director DIN 10329286
DIN 10329286 First appointment Dec 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value •••• Premium profile

About Smitha Yalamanchili

Data last updated:

Smitha Yalamanchili is a Director at Therallen Pharma Private Limited (since 2023). The company operates in Pharma. Therallen Pharma Private Limited reported revenue of ₹52.29 Cr (FY 2025).

DIN 10329286
Primary Designation Director
Industry Pharma
First Appointment 21 Dec 2023
Oldest Company Age 9 yrs
Largest company Therallen Pharma Private Limited · ₹52.29 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Therallen Pharma Private Limited U24110TG2017PTC119091
Director21 Dec 20232017₹52.29 Cr (FY 2025)Active

Board colleagues of Smitha Yalamanchili

NameDINCompanyDesignation
Srinivasa Rao Yalamanchili09162770Therallen Pharma Private LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Therallen Pharma Private Limited
Premium access

Shareholding and investment profile for Smitha Yalamanchili

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Smitha Yalamanchili

Smitha Yalamanchili currently holds 1 directorship: Therallen Pharma Private Limited (Director, since 21 Dec 2023, revenue ₹52.29 Cr (FY 2025)).

Smitha Yalamanchili was first appointed on 21 Dec 2023 as Director at Therallen Pharma Private Limited.

The current boards of Smitha Yalamanchili's companies include Srinivasa Rao Yalamanchili (Therallen Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available